multi-gene assays
The availability of multi-gene tests was most inconsistent across 53 European countries, and reimbursement was seen as the greatest barrier.
ESMO Recommendations Outline Use of Next-Gen Sequencing in Metastatic Cancer Patients
The society recommends routine use of multigene NGS for a handful of metastatic cancers, as well as in the context of clinical trials at academic centers.
Myriad Genetics Describes Advancement of Hispanic-Specific Breast Cancer Polygenic Risk Score
Premium
The studies involved data from 14,000 Hispanic women and showed the 87-SNP risk score outperformed its 86-SNP score for European women.
The agency is excluding certain advanced diagnostic lab tests and molecular pathology tests from a billing regulation that created administrative headaches for many labs.